Developing a mathematical model for the evaluation of the potential impact of a partially efficacious vaccine on the transmission dynamics of Schistosoma mansoni in human communities
Abstract Background There is currently no vaccine available to protect humans against infection with the schistosome digenean parasites, although candidate formulations for Schistosoma mansoni are under trial in animal models, including rodents and primates. Current strategies for the control of inf...
Main Authors: | Andria Stylianou, Christoforos Hadjichrysanthou, James E. Truscott, Roy M. Anderson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Parasites & Vectors |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13071-017-2227-0 |
Similar Items
-
Biomphalaria alexandrina snails as immunogens against Schistosoma mansoni infection in mice
by: Manal A Hamed, et al.
Published: (2010-11-01) -
Protective immunity induced in mice by F8.1 and F8.2 antigens purified from Schistosoma mansoni eggs
by: Claudia Campra Ferreira, et al.
Published: (1998-01-01) -
Identification of immunodominant epitopes of Schistosoma mansoni vaccine candidate antigens using human T cells
by: CT Fonseca, et al.
Published: (2004-08-01) -
Preliminary analysis of Sm14 in distinct fractions of Schistosoma mansoni adult worm extract
by: Nilton Thaumaturgo, et al.
Published: (2001-09-01) -
A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice
by: Dilhan J. Perera, et al.
Published: (2022-06-01)